Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.
Latest from Tom Gallen
A round-up of the latest appointments in Europe's consumer health industry: Dr Reddy's hires UK head; Mayoly names CEE lead; NèreS adds director.
Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.
A leading provider of over-the-counter health and wellbeing products in the DACH region will be created through the merger of Merz Lifecare and Windstar Medical.
Monaco-based Sérélys markets pollen-based supplements for a range of women's health issues, including premenstrual syndrome, postpartum discomfort and menopause.
Leadership changes at Norgine, IPHA and Orifarm feature in this week's round-up of European consumer health people news.
Food Standards Agency tells companies marketing caffeine supplements, “It is your responsibility to ensure food supplements you sell are safe for human consumption.”